HUMAN PAPILLOMA VIRUS (HPV)
Clinical trials for HUMAN PAPILLOMA VIRUS (HPV) explained in plain language.
Never miss a new study
Get alerted when new HUMAN PAPILLOMA VIRUS (HPV) trials appear
Sign up with your email to follow new studies for HUMAN PAPILLOMA VIRUS (HPV), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New wart treatment seeks final approval in major trial
Disease control Recruiting nowThis study is testing a topical liquid called YCANTH to see if it can safely and effectively clear common warts. About 300 people aged 2 and up with common warts will have the treatment or a placebo applied to their warts every few weeks. The main goal is to see how many people h…
Matched conditions: HUMAN PAPILLOMA VIRUS (HPV)
Phase: PHASE3 • Sponsor: Verrica Pharmaceuticals Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Massive health study hunts 57 hidden diseases
Knowledge-focused Recruiting nowThis study aims to understand how 57 different infectious diseases spread in Cambodian communities. Researchers will survey 10,000 people and test their blood to see which diseases they have been exposed to. The goal is to gather information to help public health officials design…
Matched conditions: HUMAN PAPILLOMA VIRUS (HPV)
Sponsor: Institut Pasteur du Cambodge • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC
-
Simple blood test could help doctors monitor cervical cancer treatment
Knowledge-focused Recruiting nowThis study is testing two different blood tests to see if they can accurately measure how well a patient's cervical cancer is responding to treatments like surgery, radiation, or chemotherapy. Researchers will check if levels of HPV-related genetic material in the blood go down w…
Matched conditions: HUMAN PAPILLOMA VIRUS (HPV)
Sponsor: University of Florida • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:41 UTC